论文部分内容阅读
美国政府卫生机构在2013年9月18日宣布,一种试验性H7N9疫苗将在美国开始人体临床试验,以验证有关疫苗的安全性以及不同剂量引起的免疫反应等关键信息。美国国家过敏症和传染病研究所所长安东尼·福奇在当天的一份声明中说,正如人们此前未曾接触的所有新型流感病毒一样,H7N9禽流感病毒有大范围流行并造成大量死亡的潜力,现在开始测试这种候选疫苗,希望能避免H7N9大流行发生。国家过敏症和传染病研究所还表示,临
The U.S. government health agency announced on September 18, 2013 that a pilot H7N9 vaccine will begin human clinical trials in the United States to verify key information about the safety of vaccines and the immune response caused by different doses. In a statement on the same day, Anthony Fauch, director of the National Institute of Allergy and Infectious Diseases, said that the H7N9 bird flu virus, like all new influenza viruses that have not been exposed before, has the potential to be widespread and cause massive deaths Now test the vaccine candidate, hoping to avoid the H7N9 pandemic. National Institute of Allergy and Infectious Diseases also said that Pro